The demand for obesity drugs in India is surging as Eli Lilly and Novo Nordisk compete. A Pakistani startup sends prosthetics ...

Reduced monthly costs for uninsured patients still amount to around $500. That can put the drugs out of reach for many.

Novo Nordisk (NVO) announced on Tuesday that it has submitted a new higher dose of its weight loss medication, Wegovy, to the European Medicines Agency for approval. The company is requesting approval ...

While Eli Lilly has struggled in the past year due to competitive pressures, the statistical winds may finally favor LLY ...